Main results: Kyphoplasty led to greater improvement in mean SF-36 physical component summary scores than did nonsurgical care (Table) . This difference remained at 3 and 6 months (Table) . The frequency of adverse events did not differ between groups. The kyphoplasty group had 2 serious adverse events (hematoma and urinary tract infection).
Conclusion:
In patients with acute vertebral compression fractures, balloon kyphoplasty was effective and safe compared with nonsurgical care. *Information provided by author.
Source of funding: Medtronic Spine. . When looking at different ages of fractures (acute, subacute, and chronic), previous studies have found differing treatment effects. The well-designed, randomized, clinical trial by Wardlaw and colleagues comparing kyphoplasty with nonsurgical care clearly shows the safety and utility of kyphoplasty to treat painful subacute compression fractures.
This study, however, does not address which method of vertebral augmentation (vertebroplasty versus kyphoplasty) is superior. Because there is a substantial cost differential between the 2 methods of augmentation, knowing which one works better is important. Fortunately, there are at least 3 randomized clinical trials (OSTEO16, KAVIAR, and CEEP) at various stages of completion that may shortly provide the answer. Until these results are known, this study shows that vertebral augmentation (via kyphoplasty) is better than traditional nonsurgical care.
